The Netherlands: Key messages to the European Commission in response to the public consultation on Pharmaceuticals – safe and affordable medicines (new EU Pharmaceutical Strategy)

The Netherlands takes the opportunity to respond to the open consultation of the European Commission on the Pharmaceutical Strategy.

Access to affordable medicines and a healthy, competitive EU market are crucial for the health of the European people and for the security and autonomy of the European Union.